3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Stroke
2
Prostatic Neoplasms
2
Osteoporosis
2
Neoplasms
2
Kidney Diseases
2
Hypertension
2
Heart Failure
2
Frailty
2
Diabetes Mellitus
2
Colorectal Neoplasms
2
Cardiovascular Diseases
2
Arthritis
2
Weight Loss
1
Rectal Neoplasms
1
Obesity-Related Malignant Neoplasm
1
Obesity
1
Neoplasm Metastasis
1
Motor Activity
1
Lung Neoplasms
1
Digestive System Carcinoma
1
Colonic Neoplasms
1
Chronic Disease
1
Bone Diseases, Metabolic
1
Interventions
fluciclovine F-18
2
Positron-Emission Tomography
2
Injections
2
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
2
pembrolizumab
1
ioflupane
1
idelalisib
1
aflibercept
1
Water
1
Vertical Dimension
1
Methylene Blue
1
Mammography
1
Drug Delivery Systems
1
Diagnosis, Computer-Assisted
1
Daunorubicin
1
Cytarabine
1
Control Groups
1
CPX-351
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Disease
×
Nutrition Assessment
×
Clear all
No trials found.